Clinical Trials

42 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT05823714 2023-04-21

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

70 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04749355 2023-03-09

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

40 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT05291390 2022-11-29

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

LymphoidOther hematologic neoplasm

200 enrolled

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04913922 2022-11-08

AARON

30 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT04689815 2022-10-04

Oral Arsenic Trioxide for NPM1-mutated AML

50 enrolled

Leukemia, Myeloid, Acute

NCT04248595 2022-09-08

Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

Leukemia, Myeloid, Acute

NCT05362942 2022-05-05

Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia

52 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT05330364 2022-04-29

Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia

31 enrolled

Leukemia, Myeloid, Acute

NCT04867928 2022-03-16

Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia

35 enrolled

Leukemia, Myeloid, Acute

NCT02071901 2021-12-01

Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

31 enrolled 14 charts

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT04752527 2021-11-15

Individualized Induction Therapy for Non-elderly Acute Myeloid Leukemia Patients With Adverse Risk Features

42 enrolled

Leukemia, Myeloid, Acute

NCT04906031 2021-06-09

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

5 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04069208 2021-06-08

IA14 Induction in Young Acute Myeloid Leukemia

42 enrolled

Leukemia, Myeloid, Acute

NCT04904237 2021-06-01

Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.

23 enrolled

Leukemia, Myeloid, Acute

NCT03080766 2021-04-28

The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype

20 enrolled

Leukemia, Myeloid, Acute

NCT02124174 2021-04-26

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Classical hematologyMyeloidOther hematologic neoplasm

50 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04824924 2021-04-01

A Phase 2 Study of Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy

Leukemia, Myeloid, Acute

NCT04254640 2020-12-17

Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

34 enrolled

Leukemia, Myeloid, Acute

NCT03135054 2020-12-10

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

40 enrolled

Leukemia, Myeloid, Acute

NCT04541277 2020-09-09

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

55 enrolled

Leukemia, Myeloid, Acute

NCT03417427 2020-04-27

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Pathologic Complete Response, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04353479 2020-04-20

Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia

29 enrolled

Leukemia, Myeloid, Acute

NCT02856464 2020-04-02

PRO-DLI

124 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02605460 2020-01-14

Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission

LymphoidOther hematologic neoplasm

20 enrolled

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03977103 2020-01-13

Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT

LymphoidMyeloidOther hematologic neoplasmPlasma cell

80 enrolled

Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03181815 2019-08-20

Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia

48 enrolled

Leukemia, Myeloid, Acute

NCT04015024 2019-07-16

A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients

30 enrolled

Leukemia, Myeloid, Acute

NCT01240525 2019-02-12

ProT4

LymphoidMyeloidOther hematologic neoplasmPlasma cell

114 enrolled

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile

NCT03454984 2018-11-15

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

40 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03381781 2018-01-04

Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations

Leukemia, Myeloid, Acute

NCT03356080 2017-11-29

DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess

50 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02899286 2017-07-28

Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

25 enrolled

Leukemia, Myeloid, Acute

NCT02802267 2017-07-02

Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

110 enrolled

Leukemia, Myeloid, Acute

NCT03053206 2017-02-15

A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia

84 enrolled

Leukemia, Myeloid, Acute

NCT03045627 2017-02-07

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

120 enrolled

Leukemia, Myeloid, Acute

NCT01690065 2016-05-11

NICE-BORA

46 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT02502968 2015-09-21

BLAST

194 enrolled

Leukemia, Myeloid, Acute

NCT00885508 2015-04-24

GFM-Chimio-Rev

85 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT02275663 2015-01-06

Azacytidine Plus FLAG for Relapsed or Refractory AML

37 enrolled

Leukemia, Myeloid, Acute

NCT00354276 2014-01-10

VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

85 enrolled

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00008307 2014-01-06

Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

52 enrolled

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

NCT00002688 2013-12-19

Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

25 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT00006084 2013-12-19

Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia